Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis

Cancer Letters

Volumn 121, Issue 1, 1997, Pages 73-81

  Park, Jeong Ae ^a   Lee, Kwang Youl ^b   Oh, Young J ^c   Kim, Kyu Won ^a   Lee, Seung Ki ^b  

^a Department of Molecular Biology   (South Korea)

^b Seoul National University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Apoptosis; Bcl 2; Caspase 3 protease; Ginsenoside Rh2 (G Rh2)

Indexed keywords

CYSTEINE PROTEINASE; DNA FRAGMENT; GINSENG SAPONIN; GINSENOSIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DNA DEGRADATION; DNA TRANSFECTION; DRUG STRUCTURE; ENZYME ACTIVATION; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASES; CELL SIZE; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENDOPEPTIDASES; ENZYME ACTIVATION; ENZYME PRECURSORS; FLOW CYTOMETRY; GINSENOSIDES; HUMANS; PANAX; PLANTS, MEDICINAL; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; SAPONINS; STAUROSPORINE; TRANSFECTION; TUMOR CELLS, CULTURED;

PANAX GINSENG;

EID: 0030777703     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00333-9     Document Type: Article

References (31)

1. 2+ channels through a pertussis toxin-sensitive G protein. Proc. Natl. Acad. Sci. USA. 92:1995;8739-8743.
2. Baek N.I., Kim D.S., Lee Y.H., Park J.D., Lee C.B., Kim S.I. Cytotoxicities of ginseng saponins and their degradation products against some cancer cell lines. Arch. Pharm. Res. 18:1995;164-168.
3. Kim Y.H., Park K.H., Rho H.M. Transcriptional activation of the Cu, Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medical plant, Panax ginseng. J. Biol. Chem. 271:1996;24539-24543.
4. Fujikawa-Yamamoto K., Ota T., Odashima S., Abe H., Arichi S. Different responses in the cell cycle of tumor cells to ginsenoside Rh2. Cancer J. 1:1987;349-352.
5. Ota T., Fujikawa-Yamamoto K., Zong Z.-p., Yamazaki M., Odashima S., Kitagawa I., Abe H., Arichi S. Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res. 47:1987;3863-3867.
6. Ota T., Maeda M., Odashima S. Mechanism of action ginsenoside Rh2: uptake and metabolism of ginsenosides Rh2 by cultured B16 melanoma cells. J. Pharm. Sci. 80:1991;1141-1146.
7. Ota T., Maeda M., Odashima S., Ninomiya-Tsuji J., Tatsuka M. G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cells. Life Sci. 60:1997;PL39-PL44.
8. Lee Y.N., Lee H.Y., Chung H.Y., Kim S.I., Lee S.K., Park B.C., Kim K.W. In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cells. Eur. J. Cancer. 32:1996;1420-1428.
9. kip1. Cancer Lett. 110:1996;193-200.
10. Kaufmann S.H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drug: a cautionary note. Cancer Res. 49:1989;5870-5878.
11. Hickmann J.A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:1992;121-139.
12. Smets L.A. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-cancer Drugs. 5:1994;3-9.
13. Chen Z., Naito M., Mashima T., Tsuruo T. Activation of actin-cleavable interleukin 1β-converting enzyme (ICE) family protease CPP32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res. 56:1996;5224-5229.
14. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
15. Rao L., White E. Bcl-2 and ICE family of apoptotic regulators: making a connection. Curr. Opin. Gene Dev. 7:1997;52-58.
16. Takahashi A., Earnshaw W.C. ICE-related proteases in apoptosis. Curr. Opin. Gene Dev. 6:1996;50-55.
17. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
18. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose)polymerase by a protease with properties like ICE. Nature. 371:1994;346-347.
19. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.-T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
20. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32β, a mammalian homolog of CED-3 is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose)polymerase. Cell. 81:1995;801-809.
21. Fernandes-Alnemri T., Litwack G., Alnemri E.S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem. 269:1994;30761-30764.
22. Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
23. Gajewski T.F., Thompson C.B. Apoptosis meets signal transduction: elimination of a BAD influence. Cell. 87:1996;589-592.
24. L function upstream of the Ced-3-like apoptotic proteases. J. Biol. Chem. 271:1996;4573-4576.
25. Shimizu S., Eguchi Y., Kamiike W., Matsuda H., Tsujimoto Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene. 12:1996;2251-2257.
26. Alley M.C., Hursey M.L., Shoemarker R.H., Mayo J.G., Monks A., Scudiero D.A., Boyd M.R., Czerwinski M.J., Fine D.L., Abbott B.J. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
27. Lamarre D., Talbot B., de Murcia G., Laplante C., Leduc Y., Mazen A., Poirier G.G. Structural and functional analysis of poly(ADP-ribose)polymerase: an immunological study. Biochim. Biophys. Acta. 950:1988;147-160.
28. Hasegawa J.-i., Kamada S., Kamiike W., Shimizu S., Imazu T., Matsuda H., Tsujimoto Y. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res. 56:1996;1713-1718.
29. Meikranz W., Gisselbrecht S., Tam S.W., Schlegel R. Activation of cyclin A-dependent protein kinase during apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;3754-3758.
30. Thornverry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.W., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., Elliston K.O., Ayala J.M., Casano F.J., Chin J., Ding G.J.-F., Egger L.A., Gaffney E.P., Limjuco G., Palyha O.C., Raju S.M., Rolando A.M., Salley J.P., Yamin T.-T., Lee T.D., Shively J.E., MacCross M., Mumford R.A., Schmidt J.A., Tocci M.J. A novel heterodimeric cysteine protease is required for inteleukin-1β processing in monocytes. Nature. 356:1992;768-774.
31. 2 homodimer. Cell. 78:1994;343-352.